Monograph Details
|
|
Urogenital System
> Miscellaneous urogenital disorders
|
|
ZEMPLAR INJECTION |
| Manufacturer |
|
Abbott Laboratories |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Vit. D analogue. |
| Generic Name |
|
Paricalcitol 2micrograms/mL; soln for IV inj; contains alcohol. |
| Also |
|
• ZEMPLAR CAPSULES
|
| Indications |
|
Secondary hyperparathyroidism due to chronic renal failure. |
| Adults and Children |
|
Give as IV bolus inj during dialysis. ≥5yrs: Initially 0.04–0.1microgram/kg (2.8–7micrograms) no more often than every other day; may increase in increments of 2–4micrograms at 2–4 week intervals; max 0.24microgram/kg (16.8micrograms). Titrate based on iPTH levels (see literature). |
| Contraindications |
|
Vit. D toxicity. Concurrent Vit. D or phosphate therapy. Hypercalcemia. |
| Precautions |
|
Severe hepatic impairment. Monitor serum calcium, phosphorus, and iPTH at least every 2 weeks for 3 months after starting or dose changes, then monthly for 3 months, then every 3 months. If hypercalcemia or elevated Ca x P product occurs, reduce dose or stop until normal; restart at lower dose. Pregnancy (Cat.C). Nursing mothers: not recommended. |
| Interactions |
|
Potentiated by potent CYP3A4 inhibitors (eg, ketoconazole). Arrhythmias with digitalis if hypercalcemia occurs. Caps: cholestyramine may impair absorption. |
| Adverse Reactions |
|
Hypercalcemia, hypercalciuria, hyperphosphatemia, suppression of PTH, hypervitaminosis D. |
| How Supplied |
Caps—30
Vial (1mL, 2mL, 4mL)—1 |
|
|
|
|
